Nucleic Acids Research, 2000, Vol. 28, No. 3 663-668
© 2000 Oxford University Press
SURVEY AND SUMMARY A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter
AIDS Molecular Biology Unit, National Centre for HIV Virology Research, The Macfarlane Burnet Centre for Medical Research, PO Box 254, Fairfield, Victoria 3078, Australia
The human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR) represents a model promoter system and the identification and characterisation of cellular proteins that interact with this region has provided a basic understanding about both general eukaryotic and HIV-1 proviral transcriptional regulation. To date a large number of sequence-specific DNA–protein interactions have been described for the HIV-1 LTR. The aim of this report is to provide a comprehensive, updated listing of these HIV-1 LTR interactions. It is intended as a reference point to facilitate on-going studies characterising the identity of cellular proteins interacting with the HIV-1 LTR and the functional role(s) of specific regions of the LTR for HIV-1 replication.
* To whom correspondence should be addressed. Tel: +61 3 9282 2234; Fax: +61 3 9482 6152; Email: deacon@burnet.edu.au Present addresses: Lloyd A. Pereira, Laboratory for Physiological Chemistry, Utrecht University, Universiteitsweg 100, 3584G CG Utrecht, The Netherlands Anna Peeters, Department of Epidemiology and Preventive Medicine, Monash Medical School, Alfred Hospital, Prahran, Victoria 3181, Australia
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H.-C. Yang, L. Shen, R. F. Siliciano, and J. L. Pomerantz Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation PNAS, April 14, 2009; 106(15): 6321 - 6326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Jablonski and M. Caputi Role of Cellular RNA Processing Factors in Human Immunodeficiency Virus Type 1 mRNA Metabolism, Replication, and Infectivity J. Virol., January 15, 2009; 83(2): 981 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Puca, G. Fiume, C. Palmieri, F. Trimboli, F. Olimpico, G. Scala, and I. Quinto I{kappa}B-{alpha} Represses the Transcriptional Activity of the HIV-1 Tat Transactivator by Promoting Its Nuclear Export J. Biol. Chem., December 21, 2007; 282(51): 37146 - 37157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Paruch, M. Heinis, J. Lemay, G. Hoeffel, C. Maranon, A. Hosmalin, and A. Perianin CCR5 signaling through phospholipase D involves p44/42 MAP-kinases and promotes HIV-1 LTR-directed gene expression FASEB J, December 1, 2007; 21(14): 4038 - 4046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Das, A. Harwig, M. M. Vrolijk, and B. Berkhout The TAR Hairpin of Human Immunodeficiency Virus Type 1 Can Be Deleted When Not Required for Tat-Mediated Activation of Transcription J. Virol., July 15, 2007; 81(14): 7742 - 7748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Nevado, S. P Tenbaum, A. I. Castillo, A. Sanchez-Pacheco, and A. Aranda Activation of the human immunodeficiency virus type I long terminal repeat by 1{alpha},25-dihydroxyvitamin D3 J. Mol. Endocrinol., June 1, 2007; 38(6): 587 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Imai and T. Okamoto Transcriptional Repression of Human Immunodeficiency Virus Type 1 by AP-4 J. Biol. Chem., May 5, 2006; 281(18): 12495 - 12505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Klichko, N. Archin, R. Kaur, G. Lehrman, and D. Margolis Hexamethylbisacetamide Remodels the Human Immunodeficiency Virus Type 1 (HIV-1) Promoter and Induces Tat-Independent HIV-1 Expression but Blunts Cell Activation J. Virol., May 1, 2006; 80(9): 4570 - 4579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Eberhardy, J. Goncalves, S. Coelho, D. J. Segal, B. Berkhout, and C. F. Barbas III Inhibition of Human Immunodeficiency Virus Type 1 Replication with Artificial Transcription Factors Targeting the Highly Conserved Primer-Binding Site J. Virol., March 15, 2006; 80(6): 2873 - 2883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Rizzi, M. P. Crippa, R. E. Jeeninga, B. Berkhout, F. Blasi, G. Poli, and M. Alfano Pertussis Toxin B-Oligomer Suppresses IL-6 Induced HIV-1 and Chemokine Expression in Chronically Infected U1 Cells via Inhibition of Activator Protein 1 J. Immunol., January 15, 2006; 176(2): 999 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. W. Gautier, N. Sheehy, M. Duffy, K. Hashimoto, and W. W. Hall Direct interaction of the human I-mfa domain-containing protein, HIC, with HIV-1 Tat results in cytoplasmic sequestration and control of Tat activity PNAS, November 8, 2005; 102(45): 16362 - 16367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Sancho, L. de la Vega, A. Macho, G. Appendino, V. Di Marzo, and E. Munoz Mechanisms of HIV-1 Inhibition by the Lipid Mediator N-Arachidonoyldopamine J. Immunol., September 15, 2005; 175(6): 3990 - 3999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lesner, Y. Li, J. Nitkiewicz, G. Li, A. Kartvelishvili, M. Kartvelishvili, and M. Simm A Soluble Factor Secreted by an HIV-1-Resistant Cell Line Blocks Transcription through Inactivating the DNA-Binding Capacity of the NF-{kappa}B p65/p50 Dimer J. Immunol., August 15, 2005; 175(4): 2548 - 2554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Goffin, D. Demonte, C. Vanhulle, S. de Walque, Y. de Launoit, A. Burny, Y. Collette, and C. Van Lint Transcription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivity Nucleic Acids Res., August 1, 2005; 33(13): 4285 - 4310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Marban, L. Redel, S. Suzanne, C. Van Lint, D. Lecestre, S. Chasserot-Golaz, M. Leid, D. Aunis, E. Schaeffer, and O. Rohr COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells Nucleic Acids Res., April 22, 2005; 33(7): 2318 - 2331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Joshi, H. Garg, M. B. Tompkins, and W. A. Tompkins Preferential Feline Immunodeficiency Virus (FIV) Infection of CD4+ CD25+ T-Regulatory Cells Correlates both with Surface Expression of CXCR4 and Activation of FIV Long Terminal Repeat Binding Cellular Transcriptional Factors J. Virol., April 15, 2005; 79(8): 4965 - 4976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chen, T. Malcolm, M. C. Estable, R. G. Roeder, and I. Sadowski TFII-I Regulates Induction of Chromosomally Integrated Human Immunodeficiency Virus Type 1 Long Terminal Repeat in Cooperation with USF J. Virol., April 1, 2005; 79(7): 4396 - 4406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Devadas, N. J. Hardegen, L. M. Wahl, I. K. Hewlett, K. A. Clouse, K. M. Yamada, and S. Dhawan Mechanisms for Macrophage-Mediated HIV-1 Induction J. Immunol., December 1, 2004; 173(11): 6735 - 6744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Sancho, N. Marquez, M. Gomez-Gonzalo, M. A. Calzado, G. Bettoni, M. T. Coiras, J. Alcami, M. Lopez-Cabrera, G. Appendino, and E. Munoz Imperatorin Inhibits HIV-1 Replication through an Sp1-dependent Pathway J. Biol. Chem., September 3, 2004; 279(36): 37349 - 37359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. van Opijnen, J. Kamoschinski, R. E. Jeeninga, and B. Berkhout The Human Immunodeficiency Virus Type 1 Promoter Contains a CATA Box Instead of a TATA Box for Optimal Transcription and Replication J. Virol., July 1, 2004; 78(13): 6883 - 6890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Segal, J. Goncalves, S. Eberhardy, C. H. Swan, B. E. Torbett, X. Li, and C. F. Barbas III Attenuation of HIV-1 Replication in Primary Human Cells with a Designed Zinc Finger Transcription Factor J. Biol. Chem., April 9, 2004; 279(15): 14509 - 14519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Hanley, H. L. B. Kiefer, A. C. Schnitzler, J. E. Marcello, and G. A. Viglianti Retinoid-Dependent Restriction of Human Immunodeficiency Virus Type 1 Replication in Monocytes/Macrophages J. Virol., March 15, 2004; 78(6): 2819 - 2830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bafica, C. A. Scanga, O. Equils, and A. Sher The induction of Toll-like receptor tolerance enhances rather than suppresses HIV-1 gene expression in transgenic mice J. Leukoc. Biol., March 1, 2004; 75(3): 460 - 466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Barzon, M. Boscaro, and G. Palu Endocrine Aspects of Cancer Gene Therapy Endocr. Rev., February 1, 2004; 25(1): 1 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Rohr, C. Marban, D. Aunis, and E. Schaeffer Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells J. Leukoc. Biol., November 1, 2003; 74(5): 736 - 749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Alfano, N. Sidenius, F. Blasi, and G. Poli The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection J. Leukoc. Biol., November 1, 2003; 74(5): 750 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Brooks, P. A. Arlen, L. Gao, C. M. R. Kitchen, and J. A. Zack Identification of T cell-signaling pathways that stimulate latent HIV in primary cells PNAS, October 28, 2003; 100(22): 12955 - 12960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Rohr, D. Lecestre, S. Chasserot-Golaz, C. Marban, D. Avram, D. Aunis, M. Leid, and E. Schaeffer Recruitment of Tat to Heterochromatin Protein HP1 via Interaction with CTIP2 Inhibits Human Immunodeficiency Virus Type 1 Replication in Microglial Cells J. Virol., May 1, 2003; 77(9): 5415 - 5427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. E. Faulkner, B. R. Lane, P. J. Bock, and D. M. Markovitz Protein Phosphatase 2A Enhances Activation of Human Immunodeficiency Virus Type 1 by Phorbol Myristate Acetate J. Virol., February 1, 2003; 77(3): 2276 - 2281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Badran, S. M. Wolinsky, A. Burny, and K. E. Willard-Gallo Identification of Three NFAT Binding Motifs in the 5'-Upstream Region of the Human CD3gamma Gene That Differentially Bind NFATc1, NFATc2, and NF-kappa B p50 J. Biol. Chem., November 27, 2002; 277(49): 47136 - 47148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Quivy, E. Adam, Y. Collette, D. Demonte, A. Chariot, C. Vanhulle, B. Berkhout, R. Castellano, Y. de Launoit, A. Burny, et al. Synergistic Activation of Human Immunodeficiency Virus Type 1 Promoter Activity by NF-{kappa}B and Inhibitors of Deacetylases: Potential Perspectives for the Development of Therapeutic Strategies J. Virol., October 2, 2002; 76(21): 11091 - 11103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Wortman, N. Darbinian, B. E. Sawaya, K. Khalili, and S. Amini Evidence for Regulation of Long Terminal Repeat Transcription by Wnt Transcription Factor TCF-4 in Human Astrocytic Cells J. Virol., October 2, 2002; 76(21): 11159 - 11165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu, J. Li, B. O. Kim, B. S. Pace, and J. J. He HIV-1 Tat Protein-mediated Transactivation of the HIV-1 Long Terminal Repeat Promoter Is Potentiated by a Novel Nuclear Tat-interacting Protein of 110 kDa, Tip110 J. Biol. Chem., June 21, 2002; 277(26): 23854 - 23863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-C. V. Hsia and Y.-B. Shi Chromatin Disruption and Histone Acetylation in Regulation of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat by Thyroid Hormone Receptor Mol. Cell. Biol., June 15, 2002; 22(12): 4043 - 4052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Marzio, M. Vink, K. Verhoef, A. de Ronde, and B. Berkhout Efficient Human Immunodeficiency Virus Replication Requires a Fine-Tuned Level of Transcription J. Virol., February 22, 2002; 76(6): 3084 - 3088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Hyun, C. Subramanian, M. A. Cotter II, R. A. Thomas, and E. S. Robertson Latency-Associated Nuclear Antigen Encoded by Kaposi's Sarcoma-Associated Herpesvirus Interacts with Tat and Activates the Long Terminal Repeat of Human Immunodeficiency Virus Type 1 in Human Cells J. Virol., September 15, 2001; 75(18): 8761 - 8771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Laprevotte, M. Pupin, E. Coward, G. Didier, C. Terzian, C. Devauchelle, and A. Henaut HIV-1 and HIV-2 LTR Nucleotide Sequences: Assessment of the Alignment by N-block Presentation, "Retroviral Signatures" of Overrepeated Oligonucleotides, and a Probable Important Role of Scrambled Stepwise Duplications/Deletions in Molecular Evolution Mol. Biol. Evol., July 1, 2001; 18(7): 1231 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bramlage, E. Luzi, and F. Eckstein HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture Nucleic Acids Res., November 1, 2000; 28(21): 4059 - 4067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Daher, M. Longuet, D. Dorin, F. Bois, E. Segeral, S. Bannwarth, P.-L. Battisti, D. F. Purcell, R. Benarous, C. Vaquero, et al. Two Dimerization Domains in the Trans-activation Response RNA-binding Protein (TRBP) Individually Reverse the Protein Kinase R Inhibition of HIV-1 Long Terminal Repeat Expression J. Biol. Chem., August 31, 2001; 276(36): 33899 - 33905. [Abstract] [Full Text] [PDF]
|
|